Cargando…
FOXA1 Leads to Aberrant Expression of SIX4 Affecting Cervical Cancer Cell Growth and Chemoresistance
Cervical cancer (CC) is among the most prevalent cancers among female populations with high recurrence rates all over the world. Cisplatin (DDP) is the first-line treatment for multiple cancers, including CC. The main problem associated with its clinical application is drug resistance. This study is...
Autores principales: | Wang, Zhuo, Sun, Bao-Sheng, Chen, Zhi-Shen, Zhao, Kang-Kang, Wang, Yun-Long, Meng, Fan-Xu, Zhang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045987/ https://www.ncbi.nlm.nih.gov/pubmed/35498155 http://dx.doi.org/10.1155/2022/9675466 |
Ejemplares similares
-
Prognostic factors for IB2-IIIB cervical cancer patients treated by radiation therapy with high-dose-rate brachytherapy in a single-institution study
por: Xiu, Yu-Ting, et al.
Publicado: (2022) -
Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPD
por: Song, J., et al.
Publicado: (2017) -
Foxa1 and Foxa2 Are Required for Formation of the Intervertebral Discs
por: Maier, Jennifer A., et al.
Publicado: (2013) -
Aberrant development of pancreatic beta cells derived from human iPSCs with FOXA2 deficiency
por: Elsayed, Ahmed K., et al.
Publicado: (2021) -
Analyses of an epigenetic switch involved in the activation of pioneer factor FOXA1 leading to the prognostic value of estrogen receptor and FOXA1 co-expression in breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)